Cargando…
Novel Neuroprotective Agents to Treat Neonatal Hypoxic-Ischemic Encephalopathy: Inter-Alpha Inhibitor Proteins
Perinatal hypoxia-ischemia (HI) is a major cause of brain injury and mortality in neonates. Hypoxic-ischemic encephalopathy (HIE) predisposes infants to long-term cognitive deficits that influence their quality of life and place a large burden on society. The only approved treatment to protect the b...
Autores principales: | Koehn, Liam M., Chen, Xiaodi, Logsdon, Aric F., Lim, Yow-Pin, Stonestreet, Barbara S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731124/ https://www.ncbi.nlm.nih.gov/pubmed/33276548 http://dx.doi.org/10.3390/ijms21239193 |
Ejemplares similares
-
Effects of Three Different Doses of Inter-Alpha Inhibitor Proteins on Severe Hypoxia–Ischemia-Related Brain Injury in Neonatal Rats
por: Koehn, Liam M., et al.
Publicado: (2022) -
Inter-Alpha Inhibitor Proteins Modify the Microvasculature after Exposure to Hypoxia–Ischemia and Hypoxia in Neonatal Rats
por: Girolamo, Francesco, et al.
Publicado: (2023) -
Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy
por: Dixon, Brandon J., et al.
Publicado: (2015) -
New possibilities for neuroprotection in neonatal hypoxic-ischemic encephalopathy
por: Victor, Suresh, et al.
Publicado: (2021) -
Hypoxic-Ischemic Neonatal Encephalopathy: Animal Experiments for Neuroprotective Therapies
por: Sameshima, Hiroshi, et al.
Publicado: (2013)